Discover how a single daily pill is transforming hypertension treatment. Simplified care and better results are reshaping patient health globally.

In March, we reported on back-to-back FDA approvals for two treatments in pulmonary arterial hypertension (PAH). In this ...

PAH, or pulmonary hypertension, can leave someone breathless even after a short walk, but better drug combinations have ...

The American Academy of Cardiology and the American Heart Association currently consider high blood pressure – also called hypertension – to be anything above 130/80. Diet is one risk factor for high ...

As prevalence of CVDs continues to increase, the AHA and AMA have developed the Target BP initiative to improve blood ...

Merck's Winrevair (sotatercept) gains UK approval for PAH treatment. Key trial results highlight significant exercise ...

Chinese scientists have found a common hypertension drug could prove potent in treating a rare but highly invasive brain ...

Adequate Sleep Significantly Reduces the Risk of Hypertension in Adolescents Nov. 11, 2024 — Adolescents who meet the recommended guidelines of nine to 11 hours of sleep per day were shown to ...

A Mendelian analysis supports the idea that hyperuricemia may be an important risk factor for pulmonary arterial hypertension ...

Tectonic's lead asset, TX45, is a long-acting Fc-relaxin fusion protein to treat group 2 pulmonary hypertension. Read why I'm ...

Adhering to the DASH diet during pregnancy significantly reduces the risk of having large-for-gestational-age (LGA) newborns, ...

The differences did not appear to be associated with potential moderating factors like age, sex, or smoking status.